PRESS RELEASE TiGenix Announces Orphan Drug Designation ODD for Cx601 in Switzerland Leuven BELGIUM October 17 2016 0700h CET TiGenix NV Euronext Brussels TIG an advanced biopharmaceutical company focused on developing and commercializing novel ther...
↧